Susquehanna International Group’s MaxCyte MXCT Stock Holding History
Bought
Maintained
Sold
Other funds holding MXCT
CFM
VP
MA
BFM
CCM
PLC
Susquehanna International Group's MXCT Position: Q2 2026 in Review
Susquehanna International Group increased its MaxCyte (MXCT) stake by 278% in Q2 2026, buying an estimated $115K and bringing the position to 156,992 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #11990.
Susquehanna International Group first reported a position in MXCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $791K in Q3 2022. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.
- Susquehanna International Group held 156,992 shares of MaxCyte worth $193K as of Q2 2026.
- Susquehanna International Group bought 115,408 MaxCyte shares in Q2 2026, an estimated $115K.
- MaxCyte made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #11990 holding.
- Susquehanna International Group first reported a position in MaxCyte in Q4 2021 and has held it in 19 quarters since.
- Susquehanna International Group's MaxCyte position peaked at $791K in Q3 2022.
- 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.